Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 10, 2010, Pages 688-698

  Zhang, Lijun ^a   Jia, Xiaofang ^a   Peng, Xia ^a   Ou, Qiang ^a   Zhang, Zhengguo ^a   Qiu, Chao ^a   Yao, Yamin ^a   Shen, Fang ^a   Yang, Hua ^a   Ma, Fang ^a   Wang, Jiefei ^a   Yuan, Zhenghong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

hepatitis B virus; LC MS; liver failure; metabonomics

Indexed keywords

GLYCEROPHOSPHORYLCHOLINE; PHOSPHATIDYLCHOLINE;

ADOLESCENT; ADULT; AGED; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; CHILD; FEMALE; HEPATITIS B; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER FAILURE; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METHODOLOGY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; RAT; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCERYLPHOSPHORYLCHOLINE; HEPATITIS B; HUMANS; LIVER FAILURE; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

HEPATITIS B VIRUS; RATTUS;

EID: 77957309530     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq078     Document Type: Article

References (32)

1. Nicholson JK, Lindon JC and Holmes E. Metabonomics: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29: 1181-1189.
2. Moco S, Schneider B and Vervoort J. Plant micrometabolomics: The analysis of endogenous metabolites present in a plant cell or tissue. J Proteome Res 2009, 8: 1694-1703.
3. Ebbels TM, Keun HC, Beckonert OP, Bollard ME, Lindon JC, Holmes E and Nicholson JK. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: The consortium on metabonomic toxicology screening approach. J Proteome Res 2007, 6: 4407-4422.
4. Bohus E, Coen M, Keun HC, Ebbels TM, Beckonert O, Lindon JC and Holmes E, et al. Temporal metabonomic modeling of l-arginine-induced exocrine pancreatitis. J Proteome Res 2008, 7: 4435-4445.
5. Griffin JL and Bollard ME. Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 2004, 5: 389-398.
6. Chan W, Lee KC, Liu N, Wong RN, Liu H and Cai Z. Liquid chromatography/ mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: The use of information-dependent acquisition for biomarker identification. Rapid Commun Mass Spectrom 2008, 22: 873-880.
7. Yu K, Sheng G, Sheng J, Chen Y, Xu W, Liu X and Cao H, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res. 2007, 6: 2413-2419.
8. Lutz U, Bittner N, Lutz RW and Lutz WK. Metabolite profiling in human urine by LC-MS/MS: Method optimization and application for glucuronides from dextromethorphan metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 871: 349-356.
9. Inagaki S, Noda T, Min JZ and Toyo'oka T. Metabolic profiling of rat hair and screening biomarkers using ultra performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. J Chromatogr A 2007, 1176: 94-99.
10. Kellert M, Wagner S, Lutz U and Lutz WK. Biomarkers of furan exposure by metabolic profiling of rat urine with liquid chromatography-tandem mass spectrometry and principal component analysis. Chem Res Toxicol 2008, 21: 761-768.
11. Want EJ, Cravatt BF and Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 2005, 6: 1941-1951.
12. Pasikanti KK, Ho PC and Chan EC. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun Mass Spectrom 2008, 22: 2984-2992.
13. Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJ, Lindon JC, Connor SC and Abdi M, et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol 1998, 11: 260-272.
14. Holmes E, Nicholson JK and Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol 2001, 14: 182-191.
15. Lenz EM and Wilson ID. Analytical strategies in metabonomics. J Proteome Res 2007, 6: 443-458.
16. Dumas ME, Maibaum EC, Teague C, Ueshima H, Zhou B, Lindon JC and Nicholson JK, et al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: The INTERMAP Study. Anal Chem 2006, 78: 2199-2208.
17. Maher AD, Zirah SF, Holmes E and Nicholson JK. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal Chem 2007, 79: 5204-5211.
18. Wagner S, Scholz K, Sieber M, Kellert M and Voelkel W. Tools in metabonomics: An integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine. Anal Chem 2007, 79: 2918-2926.
19. Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S and Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 813: 59-65.
20. Michopoulos F, Lai L, Gika H, Theodoridis G and Wilson I. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J Proteome Res 2009, 8: 2114-2121.
21. Potts BC, Deese AJ, Stevens GJ, Reily MD, Robertson DG and Theiss J. NMR of biofluids and pattern recognition: Assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse. J Pharm Biomed Anal 2001, 26: 463-476.
22. Seierstad T, RØe K, Sitter B, Halgunset J, Flatmark K, Ree AH and Olsen DR, et al. Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy. Mol Cancer 2008, 7: 33.
23. Krug D, Zurek G, Schneider B, Garcia R and Muller R. Efficient mining of myxobacterial metabolite profiles enabled by liquid chromatographyelectrospray ionisation-time-of-flight mass spectrometry and compoundbased principal component analysis. Anal Chim Acta 2008, 624: 97-106.
24. Ru QC, Zhu LA, Silberman J and Shriver CD. Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry. Mol Cell Proteomics 2006, 5: 1095-1104.
25. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL and Park BK. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 877: 1229-1239.
26. Yeung KY and Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 2001, 17: 763-774.
27. Weckwerth W. Metabolomics in systems biology. Annu Rev Plant Biol 2003, 54: 669-689.
28. Arai K, Lee K, Berthiaume F, Tompkins RG and Yarmush ML. Intrahepatic amino acid and glucose metabolism in a D-galactosamineinduced rat liver failure model. Hepatology 2001, 34: 360-371.
29. Mao Y, Huang X, Yu K, Qu HB, Liu CX and Cheng YY. Metabonomic analysis of hepatitis B virus-induced liver failure: Identification of potential diagnostic biomarkers by fuzzy support vector machine. J Zhejiang Univ Sci B 2008, 9: 474-481.
30. Cao Q, Mak KM and Lieber CS. Dilinoleoylphosphatidylcholine decreases acetaldehyde-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats. Biochem Biophys Res Commun 2002, 299: 459-464.
31. Aleynik MK and Lieber CS. Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1. Biochem Biophys Res Commun 2001, 288: 1047-1051.
32. Aleynik SI, Leo MA, Takeshige U, Aleynik MK and Lieber CS. Dilinoleoylphosphatidylcholine is the active antioxidant of polyenylphosphatidylcholine. J Investig Med 1999, 47: 507-512.